TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin β receptor signaling

被引:45
作者
Kim, YS
Nedospasov, SA
Liu, ZG
机构
[1] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] SAIC Frederick Inc, Basic Res Program, Frederick, MD USA
[3] NCI, Mol Immunoregulat Lab, Frederick, MD 21701 USA
关键词
D O I
10.1128/MCB.25.6.2130-2137.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LIGHT is a member of the tumor necrosis factor (TNF) superfamily, and its function is mediated by at least two receptors, including lymphotoxin P receptor (LTbetaR) and herpes simplex virus entry mediator. However, the molecular mechanism of LIGHT signaling mediated by LTbetaR has not been clearly defined. In this report, we demonstrate that TRAF2 is critical for LIGHT- and LTbetaR-mediated activation of both the transcription factor NF-kappaB and the mitogen-activated protein kinase JNK. In HeLa cells, LIGHT induces NF-kappaB and JNK activation, which can be blocked by the dominant negative mutant of TRAF2. In these cells, LIGHT causes the recruitment of TRAF2, TRAF3, and IkappaB kinase into the LTbetaR complex. Importantly, while both NF-kappaB and JNK are activated by LIGHT in wild-type mouse embryonic fibroblasts, no activation of either of these two pathways is observed in TRAF2 null fibroblasts. However, LIGHT-induced NF-kappaB and JNK activation can be restored by ectopic expression of TRAF2 in TRAF(-/-) cells. Interestingly, in contrast to TNF signaling, the activation of both NF-kappaB and JNK by LIGHT was normal in RIP-/- and TRAF5(-/-) cells. Taken together, our data demonstrate that TRAF2, an important effector molecule of TNF signaling, plays a critical, nonredundant role in LIGHT-LTbetaR signaling.
引用
收藏
页码:2130 / 2137
页数:8
相关论文
共 56 条
[1]   Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain [J].
Baud, V ;
Liu, ZG ;
Bennett, B ;
Suzuki, N ;
Xia, Y ;
Karin, M .
GENES & DEVELOPMENT, 1999, 13 (10) :1297-1308
[2]  
Betts JC, 1996, MOL CELL BIOL, V16, P6363
[3]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[4]   Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines [J].
Browning, JL ;
Miatkowski, K ;
Sizing, I ;
Griffiths, D ;
Zafari, M ;
Benjamin, CD ;
Meier, W ;
Mackay, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :867-878
[5]   Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses [J].
Caamaño, JH ;
Rizzo, CA ;
Durham, SK ;
Barton, DS ;
Raventós-Suárez, C ;
Snapper, CM ;
Bravo, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :185-196
[6]  
Chankowski PH, 2002, J HIGH ENERGY PHYS
[7]  
DAIS RJ, 1999, BIOCH SOC S, V64, P1
[8]  
DegliEsposti MA, 1997, J IMMUNOL, V158, P1756
[9]   The signaling adaptors and pathways activated by TNF superfamily [J].
Dempsey, PW ;
Doyle, SE ;
He, JQ ;
Cheng, GH .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (3-4) :193-209
[10]   The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation [J].
Devin, A ;
Cook, A ;
Lin, Y ;
Rodriguez, Y ;
Kelliher, M ;
Liu, ZG .
IMMUNITY, 2000, 12 (04) :419-429